Anderson Woodrow D — SEC Form 4 filings

SEC reporting owner CIK 2014440. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-27.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2026-02-12 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Indivior Pharmaceuticals, Inc. (INDV)Chief Accounting Officer42 legs · 3,000 sh · $107,9558

Form 4 filings — Anderson Woodrow D

FiledFormIssuerReported transactionsSource
2026-08-274Indivior Pharmaceuticals, Inc. (INDV)Purchase (P): 1,500 @ $35.69EDGAR
2026-08-054Indivior Pharmaceuticals, Inc. (INDV)Purchase (P): 1,500 @ $36.28EDGAR
2026-03-054Indivior Pharmaceuticals, Inc. (INDV)Option exercise (M): 18,364 · Tax withholding (F): 8,283 @ $31.98 · Option exercise (M): 5,946 · Tax withholding (F): 2,682 @ $31.98 · Option exercise (M): 23,975 (derivative) · Option exercise (M): 5,946 (derivative)EDGAR
2026-02-124Indivior Pharmaceuticals, Inc. (INDV)Grant/award (A): 6,903 @ $0 · Grant/award (A): 23,975 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2014440 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →